Aquilo Capital, L.P., 10% Owner at Spero Therapeutics, Inc. (SPRO), bought 798,390 shares at $14.86 ($12.4M) on 2021-08-20, disclosed to the SEC on 2021-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.86 | 221,190 | $3.3M | 26.5% |
| 2 | $14.86 | 221,190 | $3.3M | 26.5% |
| 3 | $16.33 | 137,835 | $2.3M | 18.2% |
| 4 | $16.33 | 137,835 | $2.3M | 18.2% |
| 5 | $16.28 | 40,170 | $654K | 5.3% |
| 6 | $16.28 | 40,170 |
| $654K |
| 5.3% |
| Total | $15.51 avg | 798,390 | $12.4M | 100% |
| Filing → |
| SPRO | BUY | 2022-03-02 | $855K | — | Filing → |
| SPRO | BUY | 2022-01-26 | $17K | — | Filing → |
| SPRO | BUY | 2021-11-02 | $2.6M | — | Filing → |